Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials for Cancer in United States

6988 results

Sort By:

Trastuzumab Deruxtecan (T-DXd) in Patients Who Have Hormone Receptor-negative and Hormone Receptor-positive HER2-low or HER2 IHC 0 Metastatic Breast Cancer

Study ID: NCT05950945
Start Date: 2023-12-30
End Date: 2027-10-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

250

Intervention / Treatment

Trastuzumab Deruxtecan

Sponsor

Daiichi Sankyo

Source: clinicaltrials.gov

Share:
Add to list

Pembrolizumab and Mogamulizumab in Advanced-stage, Relapsed/Refractory Cutaneous T-cell Lymphomas

Study ID: NCT05956041
Start Date: 2023-12-06
End Date: 2026-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

23

Intervention / Treatment

Pembrolizumab

Mogamulizumab

Sponsor

University of Michigan Rogel Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Adenosine Signaling Modulation and Immune Checkpoint Inhibition With Hormone Sensitive Oligometastatic Prostate Cancer

Study ID: NCT05915442
Start Date: 2023-07-01
End Date: 2028-12
Study Type

Interventional

Study Phase

Phase2

No. of Participants

23

Intervention / Treatment

He listens

Etrumadenant

Zimberelimab

Stereotactic Body Radiation Therapy

Sponsor

Catherine Spina

Source: clinicaltrials.gov

Share:
Add to list

Enhancing Access to Supportive Services for Women of Color With Metastatic Breast Cancer

Study ID: NCT06405828
Start Date: 2024-05-01
End Date: 2026-11-30
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

67

Intervention / Treatment

ACCESS Supportive Care

Phone sessions

Sponsor

Icahn School of Medicine at Mount Sinai

Source: clinicaltrials.gov

Share:
Add to list

Improving Cognitive Function Through High-intensity Interval Training in Breast Cancer Patients Undergoing Chemotherapy

Study ID: NCT04724499
Start Date: 2021-07-14
End Date: 2026-06-15
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

30

Intervention / Treatment

High-Intensity Intervals Training

Attention Control

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

Study ID: NCT06626919
Start Date: 2025-04-30
End Date: 2028-04
Study Type

Interventional

Study Phase

Phase1

No. of Participants

30

Intervention / Treatment

anito-cel

Standard Lymphodepletion regimen

Sponsor

Arcellx, Inc.

Source: clinicaltrials.gov

Share:
Add to list

Brain [18F]-FES PET/CT in Patients With Estrogen-Receptor Positive Breast Cancer

Study ID: NCT06072807
Start Date: 2023-12-27
End Date: 2027-12
Study Type

Interventional

Study Phase

Phase4

No. of Participants

20

Intervention / Treatment

Brain Imaging with 18F-FES

Sponsor

Weill Medical College of Cornell University

Source: clinicaltrials.gov

Share:
Add to list

TeleHealth Resistance Exercise Intervention to Preserve Dose Intensity and Vitality in Elder Breast Cancer Patients

Study ID: NCT05535192
Start Date: 2023-03-20
End Date: 2027-02-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

270

Intervention / Treatment

THRIVE

Health Education Support Program

Sponsor

Dana-Farber Cancer Institute

Source: clinicaltrials.gov

Share:
Add to list

Communication About Sexual Health in Gynecologic Cancer

Study ID: NCT06904339
Start Date: 2025-02-20
End Date: 2028-08-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

200

Intervention / Treatment

Starting the Conversation

Sexual Health Resources

Sponsor

Fox Chase Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Validation of Pre-clinical Nano-Based Analgesics in Cells From Human Dorsal Root Ganglia

Study ID: NCT04533919
Start Date: 2020-06-16
End Date: 2027-04-30
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

8

Intervention / Treatment

Biospecimen Collection

Sponsor

M.D. Anderson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list